Brevan Howard Capital Management LP Grows Stake in AMETEK, Inc. $AME

Brevan Howard Capital Management LP boosted its stake in shares of AMETEK, Inc. (NYSE:AMEFree Report) by 310.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 63,792 shares of the technology company’s stock after acquiring an additional 48,233 shares during the quarter. Brevan Howard Capital Management LP’s holdings in AMETEK were worth $11,544,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of AME. SouthState Corp increased its position in shares of AMETEK by 47.4% during the 2nd quarter. SouthState Corp now owns 202 shares of the technology company’s stock valued at $37,000 after purchasing an additional 65 shares during the last quarter. Signature Estate & Investment Advisors LLC boosted its stake in AMETEK by 3.9% during the first quarter. Signature Estate & Investment Advisors LLC now owns 1,784 shares of the technology company’s stock worth $307,000 after buying an additional 67 shares during the period. First Horizon Advisors Inc. boosted its stake in AMETEK by 3.0% during the second quarter. First Horizon Advisors Inc. now owns 2,335 shares of the technology company’s stock worth $423,000 after buying an additional 69 shares during the period. Summit Financial LLC increased its position in AMETEK by 2.6% during the first quarter. Summit Financial LLC now owns 3,451 shares of the technology company’s stock valued at $594,000 after acquiring an additional 89 shares during the last quarter. Finally, Leavell Investment Management Inc. raised its stake in shares of AMETEK by 2.2% in the second quarter. Leavell Investment Management Inc. now owns 4,468 shares of the technology company’s stock valued at $809,000 after acquiring an additional 96 shares during the period. 87.43% of the stock is owned by institutional investors.

Insider Activity

In other news, CEO David A. Zapico sold 28,390 shares of the company’s stock in a transaction that occurred on Friday, December 12th. The shares were sold at an average price of $201.76, for a total value of $5,727,966.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Ronald J. Oscher sold 26,290 shares of AMETEK stock in a transaction that occurred on Friday, October 31st. The shares were sold at an average price of $200.05, for a total transaction of $5,259,314.50. Following the transaction, the insider directly owned 40,226 shares in the company, valued at approximately $8,047,211.30. The trade was a 39.52% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 142,680 shares of company stock valued at $28,269,601. Company insiders own 0.57% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently commented on AME. Truist Financial upped their price target on shares of AMETEK from $219.00 to $229.00 and gave the company a “buy” rating in a report on Wednesday, October 8th. TD Cowen raised AMETEK from a “sell” rating to a “hold” rating and upped their target price for the company from $158.00 to $180.00 in a research note on Tuesday, September 2nd. Barclays increased their price target on AMETEK from $200.00 to $205.00 and gave the stock an “equal weight” rating in a report on Friday, October 31st. Robert W. Baird upped their price objective on AMETEK from $198.00 to $204.00 and gave the company a “neutral” rating in a research report on Monday, November 3rd. Finally, DA Davidson increased their target price on AMETEK from $235.00 to $240.00 and gave the stock a “buy” rating in a research note on Monday. Eight research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $213.08.

Get Our Latest Research Report on AMETEK

AMETEK Stock Down 1.1%

Shares of NYSE:AME opened at $201.62 on Friday. The business’s 50 day moving average is $192.57 and its 200 day moving average is $186.06. The stock has a market cap of $46.41 billion, a P/E ratio of 31.80, a price-to-earnings-growth ratio of 2.90 and a beta of 1.04. AMETEK, Inc. has a 52-week low of $145.02 and a 52-week high of $204.43. The company has a quick ratio of 0.72, a current ratio of 1.16 and a debt-to-equity ratio of 0.14.

AMETEK (NYSE:AMEGet Free Report) last issued its earnings results on Thursday, October 30th. The technology company reported $1.89 earnings per share for the quarter, topping the consensus estimate of $1.76 by $0.13. The business had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $1.81 billion. AMETEK had a return on equity of 16.66% and a net margin of 20.50%.The business’s revenue for the quarter was up 10.8% compared to the same quarter last year. During the same period in the prior year, the business earned $1.66 EPS. AMETEK has set its Q4 2025 guidance at 1.900-1.950 EPS and its FY 2025 guidance at 7.320-7.370 EPS. Sell-side analysts predict that AMETEK, Inc. will post 7.15 EPS for the current year.

AMETEK Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 19th. Shareholders of record on Friday, December 5th will be given a dividend of $0.31 per share. The ex-dividend date of this dividend is Friday, December 5th. This represents a $1.24 dividend on an annualized basis and a yield of 0.6%. AMETEK’s dividend payout ratio (DPR) is 19.56%.

AMETEK Profile

(Free Report)

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.

Recommended Stories

Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AMEFree Report).

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.